Literature DB >> 15310255

Acute clinical ethics consultation: the practicalities.

Andrew W Gill1, Peter Saul, John McPhee, Ian Kerridge.   

Abstract

In Australia there has been only limited experience with ethics consultation, and there are no reports of practical details. In 1999, the Institutional Clinical Ethics Committee at John Hunter Hospital, Newcastle, initiated an Acute Clinical Ethics Service (ACES) to formalise a perceived need within the hospital for ethics consultation. This need had previously been met by ad-hoc councils of "wise men". The ACES approach uses a team of people with different perspectives to provide an ethics consultation in a timely manner. Our initial experience of ACES has shown that a formal process of ethics consultation may be preferable to informal approaches in many circumstances; even when genuine consensus is not possible, an ethics consultation nevertheless provides an opportunity to share different points of view and helps to avoid practices that may be unacceptable. The specific implications of acute ethics consultations are not yet fully elucidated.

Entities:  

Keywords:  Bioethics and Professional Ethics

Mesh:

Year:  2004        PMID: 15310255     DOI: 10.5694/j.1326-5377.2004.tb06237.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

1.  Confidentiality, secrecy and privacy in ethics consultation.

Authors:  Gerald Neitzke
Journal:  HEC Forum       Date:  2007-12

2.  Clinical ethics support services in paediatric practice: protocol for a mixed studies systematic review on structures, interventions and outcomes.

Authors:  Mariana Dittborn; Bernardita Portales; Joe Brierley
Journal:  BMJ Open       Date:  2022-04-08       Impact factor: 2.692

3.  Clinical ethics consultation: examining how American and Japanese experts analyze an Alzheimer's case.

Authors:  Noriko Nagao; Mark P Aulisio; Yoshio Nukaga; Misao Fujita; Shinji Kosugi; Stuart Youngner; Akira Akabayashi
Journal:  BMC Med Ethics       Date:  2008-01-29       Impact factor: 2.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.